J. Willerson

Surgery · 2000–2009

A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Surgery — 66 citations into it; #995 of 1,106 by trust here, #71 by citations
• Cardiology and Cardiovascular Medicine — 44 citations into it; #350 of 906 by trust here, #77 by citations
• Epidemiology — 30 citations into it; #1,322 of 2,148 by trust here, #219 by citations

Whom J. Willerson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Ridker
2. Peter Libby

Who trusts J. Willerson overall

1. M. Félétou
2. P. M. Vanhoutte
3. A. Kontush
4. G. Lopaschuk
5. D. Konukoğlu
6. Paula Pereira
7. S. Verma
8. P. Ridker
9. A. Grebe

Papers from J. Willerson's perspective

Ordered by how strongly the researchers J. Willerson trusts endorse each paper. Same corpus, a different order for every researcher.

1. Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein (Circulation)
2. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study (Circulation)
3. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. (Arteriosclerosis, Thrombosis and Vascular Biology)
4. The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes (Current Opinion in Cardiology)
5. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells (Circulation)
6. Task Force on Sudden Cardiac Death of the European Society of Cardiology. (European Heart Journal)
7. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. (Circulation)
8. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits (Circulation)
9. Relationship Between Coronary Artery Remodeling and Plaque Vulnerability (Circulation)
10. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. (New England Journal of Medicine)

Their papers

• Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. (2009) — 1,030 citations
• A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism: the JUPITER Trial (2009) — 730 citations
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (2008) — 6,106 citations
• Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. (2006) — 620 citations
• Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model (2005) — 802 citations
• Inflammation as a Cardiovascular Risk Factor (2004) — 1,363 citations
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) — 1,291 citations
• Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure (2003) — 1,373 citations
• Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-&agr;, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial (2003) — 1,495 citations
• From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) — 3,137 citations
• Endothelial dysfunction. (2003) — 1,635 citations
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells (2000) — 2,064 citations